Literature DB >> 16556576

Mixed-micellar proliposomal systems for enhanced oral delivery of progesterone.

Praveen Potluri1, Guru V Betageri.   

Abstract

The objective of our study was to develop a mixed-micellar proliposomal formulation of poorly water-soluble drug progesterone and evaluate the dissolution profile and membrane transport. Several formulations of proliposomes were prepared by mixing different concentrations of lipid, progesterone, polysorbate 80, and microcrystalline cellulose. The mixed-micellar formulation of drug:dimyristoyl-phosphatidycholine:polysorbate 80 (1:20:3.3) exhibited the maximum dissolution (75.27%), while pure progesterone resulted in low dissolution. The above formulation showed a 4-fold increase in transport in Caco-2 cells and a 6-fold increase in transport across the everted rat intestinal sac experiments compared with control. Proliposomal formulations enhance the extent of dissolution and membrane transport of progesterone and serve as ideal carriers for oral delivery of drugs with low water solubility.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16556576     DOI: 10.1080/10717540500395007

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  5 in total

Review 1.  Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance.

Authors:  Angel Tan; Shasha Rao; Clive A Prestidge
Journal:  Pharm Res       Date:  2013-06-18       Impact factor: 4.200

Review 2.  Phospholipids and lipid-based formulations in oral drug delivery.

Authors:  Gert Fricker; Torsten Kromp; Armin Wendel; Alfred Blume; Jürgen Zirkel; Herbert Rebmann; Constanze Setzer; Ralf-Olaf Quinkert; Frank Martin; Christel Müller-Goymann
Journal:  Pharm Res       Date:  2010-04-22       Impact factor: 4.200

3.  Hyaluronic acid-modified didecyldimethylammonium bromide/ d-a-tocopheryl polyethylene glycol succinate mixed micelles for delivery of baohuoside I against non-small cell lung cancer: in vitro and in vivo evaluation.

Authors:  Hongmei Yan; Jie Song; Xiaobin Jia; Zhenhai Zhang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

4.  ATR/Raman and fractal characterization of HPBCD/progesterone complex solid particles.

Authors:  Adamo Fini; Francesca Ospitali; Giorgio Zoppetti; Nadia Puppini
Journal:  Pharm Res       Date:  2008-07-03       Impact factor: 4.580

5.  A New Type of Liquid Silymarin Proliposome Containing Bile Salts: Its Preparation and Improved Hepatoprotective Effects.

Authors:  Mei Wang; Tingting Xie; Zhanying Chang; Ling Wang; Xiangyun Xie; Yaohong Kou; Hongxia Xu; Xiaoli Gao
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.